Old Web
English
Sign In
Acemap
>
Paper
>
423 A phase 2 study of ibrutinib as neoadjuvant therapy in patients with localized prostate cancer
423 A phase 2 study of ibrutinib as neoadjuvant therapy in patients with localized prostate cancer
2021
Russell K. Pachynski
Melissa A. Reimers
Cody Weimholt
Katie Slane
Peter Oppelt
Jason Frankel
Robert S. Figenshau
Eric H. Kim
Gerald L. Andriole
Lawrence Fong
Keywords:
Oncology
Internal medicine
Ibrutinib
in patient
Neoadjuvant therapy
Phases of clinical research
Prostate cancer
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]